Cytomegalic Inclusion Disease - 25 Studies Found Recruiting : Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients : Cytomegalovirus Disease : 2009-01-23 : Drug: Certican (everolimus) + valganciclovir Completed : Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection : Cytomegalovirus Disease : 2012-01-10 : Drug: Valganciclovir Valcyte p Completed : A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients : Cytomegalovirus Infections : 2012-12-17 : Drug: MCMV3068A Four doses of Terminated : SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients : Cytomegalovirus Disease : 2015-05-07 : Drug: Brincidofovir Other Name Enrolling by invitation : Screening for Congenital Cytomegalovirus Infection in Newborns : Cytomegalovirus Infections : 2016-02-11 : Other: Observation Viable Infants with a failed hearing screen or a diagnosis of SGA who are born at eit Recruiting : Preemptive Adoptive CMV-CTL Infusion to Prevent Refractory CMV Infection Post Haplo-HSCT : CMV Infection : 2016-11-28 : Biological: Donor-derived CMVpp65-specific T cells About 1 million per kg CMVpp65-specific T cells will Completed : Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients : Cytomegalovirus Infection : 2008-10-15 Recruiting : Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection : Cytomegalovirus Infections : 2012-05-17 Completed : Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections : Cytomegalovirus Infection : 2007-04-26 : Other: Placebo 9 grams of powd Completed : Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection : Cytomegalovirus Infection : 2009-04-14 : Drug: HCMV-specific hyperimmune globulin (Cytotect®) Next >>>